282 related articles for article (PubMed ID: 22171009)
1. Structure-based design of conformation- and sequence-specific antibodies against amyloid β.
Perchiacca JM; Ladiwala AR; Bhattacharya M; Tessier PM
Proc Natl Acad Sci U S A; 2012 Jan; 109(1):84-9. PubMed ID: 22171009
[TBL] [Abstract][Full Text] [Related]
2. Nature-inspired design and evolution of anti-amyloid antibodies.
Julian MC; Rabia LA; Desai AA; Arsiwala A; Gerson JE; Paulson HL; Kane RS; Tessier PM
J Biol Chem; 2019 May; 294(21):8438-8451. PubMed ID: 30918024
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies against Aβ42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain.
Hatami A; Albay R; Monjazeb S; Milton S; Glabe C
J Biol Chem; 2014 Nov; 289(46):32131-32143. PubMed ID: 25281743
[TBL] [Abstract][Full Text] [Related]
4. Rational design of potent domain antibody inhibitors of amyloid fibril assembly.
Ladiwala AR; Bhattacharya M; Perchiacca JM; Cao P; Raleigh DP; Abedini A; Schmidt AM; Varkey J; Langen R; Tessier PM
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):19965-70. PubMed ID: 23161913
[TBL] [Abstract][Full Text] [Related]
5. Amyloid fibril recognition with the conformational B10 antibody fragment depends on electrostatic interactions.
Haupt C; Morgado I; Kumar ST; Parthier C; Bereza M; Hortschansky P; Stubbs MT; Horn U; Fändrich M
J Mol Biol; 2011 Jan; 405(2):341-8. PubMed ID: 21059358
[TBL] [Abstract][Full Text] [Related]
6. Design and Optimization of Anti-amyloid Domain Antibodies Specific for β-Amyloid and Islet Amyloid Polypeptide.
Lee CC; Julian MC; Tiller KE; Meng F; DuConge SE; Akter R; Raleigh DP; Tessier PM
J Biol Chem; 2016 Feb; 291(6):2858-73. PubMed ID: 26601942
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of recognition of amyloid-β (Aβ) monomer, oligomer, and fibril by homologous antibodies.
Zhao J; Nussinov R; Ma B
J Biol Chem; 2017 Nov; 292(44):18325-18343. PubMed ID: 28924036
[TBL] [Abstract][Full Text] [Related]
8. Human plasma contains cross-reactive Abeta conformer-specific IgG antibodies.
O'Nuallain B; Acero L; Williams AD; Koeppen HP; Weber A; Schwarz HP; Wall JS; Weiss DT; Solomon A
Biochemistry; 2008 Nov; 47(47):12254-6. PubMed ID: 18956886
[TBL] [Abstract][Full Text] [Related]
9. Structural differences of amyloid-β fibrils revealed by antibodies from phage display.
Droste P; Frenzel A; Steinwand M; Pelat T; Thullier P; Hust M; Lashuel H; Dübel S
BMC Biotechnol; 2015 Jun; 15():57. PubMed ID: 26084577
[TBL] [Abstract][Full Text] [Related]
10. Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer's disease.
Murakami K
Biosci Biotechnol Biochem; 2014; 78(8):1293-305. PubMed ID: 25130729
[TBL] [Abstract][Full Text] [Related]
11. Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.
Robert R; Lefranc MP; Ghochikyan A; Agadjanyan MG; Cribbs DH; Van Nostrand WE; Wark KL; Dolezal O
Mol Immunol; 2010; 48(1-3):59-72. PubMed ID: 20970857
[TBL] [Abstract][Full Text] [Related]
12. The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
Colvin BA; Rogers VA; Kulas JA; Ridgway EA; Amtashar FS; Combs CK; Nichols MR
J Neurochem; 2017 Dec; 143(6):736-749. PubMed ID: 28881033
[TBL] [Abstract][Full Text] [Related]
13. A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid β and elicits antibodies against oligomeric and fibrillar amyloid and plaques.
Hoogerhout P; Kamphuis W; Brugghe HF; Sluijs JA; Timmermans HA; Westdijk J; Zomer G; Boog CJ; Hol EM; van den Dobbelsteen GP
PLoS One; 2011 Apr; 6(4):e19110. PubMed ID: 21526148
[TBL] [Abstract][Full Text] [Related]
14. Uncovering the Binding and Specificity of β-Wrapins for Amyloid-β and α-Synuclein.
Orr AA; Wördehoff MM; Hoyer W; Tamamis P
J Phys Chem B; 2016 Dec; 120(50):12781-12794. PubMed ID: 27934063
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers.
Ladiwala AR; Lin JC; Bale SS; Marcelino-Cruz AM; Bhattacharya M; Dordick JS; Tessier PM
J Biol Chem; 2010 Jul; 285(31):24228-37. PubMed ID: 20511235
[TBL] [Abstract][Full Text] [Related]
16. Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity.
Desai AA; Smith MD; Zhang Y; Makowski EK; Gerson JE; Ionescu E; Starr CG; Zupancic JM; Moore SJ; Sutter AB; Ivanova MI; Murphy GG; Paulson HL; Tessier PM
J Biol Chem; 2021; 296():100508. PubMed ID: 33675750
[TBL] [Abstract][Full Text] [Related]
17. Structures of Abeta-related peptide--monoclonal antibody complexes.
Gardberg A; Dice L; Pridgen K; Ko J; Patterson P; Ou S; Wetzel R; Dealwis C
Biochemistry; 2009 Jun; 48(23):5210-7. PubMed ID: 19385664
[TBL] [Abstract][Full Text] [Related]
18. Molecular interactions between monoclonal oligomer-specific antibody 5E3 and its amyloid beta cognates.
Khorvash M; Blinov N; Ladner-Keay C; Lu J; Silverman JM; Gibbs E; Wang YT; Kovalenko A; Wishart D; Cashman NR
PLoS One; 2020; 15(5):e0232266. PubMed ID: 32469918
[TBL] [Abstract][Full Text] [Related]
19. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
20. Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.
Moretto N; Bolchi A; Rivetti C; Imbimbo BP; Villetti G; Pietrini V; Polonelli L; Del Signore S; Smith KM; Ferrante RJ; Ottonello S
J Biol Chem; 2007 Apr; 282(15):11436-45. PubMed ID: 17267402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
